Isolation of CD3+ T cells and CD19+ B cells from buffy coats from healthy blood donors, and peripheral blood mononuclear cells (PBMCs) from CLL patient samples, was performed as described [23, 24]. Isolated cells were cryopreserved in liquid nitrogen [24]. See Table 2 for patient characteristics.
Patient characteristics. B, bendamustine; C, cyclophosphamide; F, fludarabine; R, rituximab; f, female; m. male; M, mutated IGVH; n.e., not established; OFA, ofatumumab; UM, unmutated IGVH.
Samples collected
(if more than one)
Idelalisib
(with OFA at initiation)
Idelalisib
(with OFA at initiation)
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.